Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals

US6506778B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Elisabeth Defossa · Idstein, DE
• Thomas Klabunde · Frankfurt, DE
• Hans-Joerg Burger · Morristown, US
• Andreas Herling · Bad Camberg, DE
• Karl-Heinz Baringhaus · Blieskastel, DE

Key dates

• Filing date: Jun 8, 2001
• Grant date: Jan 14, 2003
• Expiry date: Jun 8, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D307/38
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention is directed to acylphenylurea derivatives and their physiologically tolerated salts and physiologically functional derivatives.Compounds of the formula I in which the radicals have the stated meanings, and their physiologically tolerated salts and a process for their preparation are described. The compounds are suitable, for example, for treating type II diabetes.